Kemp Dolliver analyst BROOKLINE

Currently out of the existing stock ratings of Kemp Dolliver, 25 are a BUY (89.29%), 3 are a HOLD (10.71%).

Kemp Dolliver

Work Performance Price Targets & Ratings Chart

Analyst Kemp Dolliver, currently employed at BROOKLINE, has had 48.48% of price targets met with an average potential upside of 54.27%, reached in 139 days on average.

Kemp Dolliver has documented 51 price targets and ratings displayed on 15 stocks. The coverage is on Healthcare, Energy sectors.

Most recent stock forecast was given on LNTH, at 09-Apr-2026.

Wall Street Analyst Kemp Dolliver

Analyst best performing recommendations are on MNPR.
The best stock recommendation documented was for MNPR on 9/25/2025. The price target of $93 was fulfilled within 7 days with a profit of $15.56 (20.09%), with a performance score of 28.7.

Average potential price target upside

  • of $27.64 (43.28%) on LNTH.
  • of $15.83 (32.47%) on MNPR.
  • of $0.98 (83.64%) on IBIO.
ECOR VRCA PNT POINT Biopharma Global DARE BLPH Bellerophon Therapeutics IBIO MNPR ICCM OTLK OUTLOOK THERAPEUTICS INC SCYX LNTH

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Mar-2020

$18

$13.58 (307.24%)

$18

8 months 2 days ago
(20-Mar-2026)

7/12 (58.33%)

$11.75 (188.00%)

382

Buy Since 27-Jul-2021

$26

$45

1 years 8 months 9 days ago
(13-Mar-2025)

0/2 (0%)

$16.45 (172.25%)

Buy Since 13-Jan-2023

$18.75

3 years 10 months 9 days ago
(13-Jan-2023)

1/1 (100%)

$14.22 (313.91%)

768

Buy Since 30-Sep-2020

$22.5

$45

4 years 8 months 11 days ago
(11-Mar-2022)

1/2 (50%)

$14.32 (175.06%)

118

Hold Since 14-Aug-2020

$52.5

6 years 3 months 8 days ago
(14-Aug-2020)

0/2 (0%)

$18.45 (54.19%)

Show more analysts

Stocks Kemp Dolliver covered previously. Scores are shown for active stocks only.

NOV NOV ONCT YMAB

Please expand the browser size to see the chart

What Year was the first public recommendation made by Kemp Dolliver?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?